Impact of NQO1 dysregulation in CNS disorders

Li Yuhan,Maryam Khaleghi Ghadiri,Ali Gorji
DOI: https://doi.org/10.1186/s12967-023-04802-3
IF: 8.44
2024-01-02
Journal of Translational Medicine
Abstract:Abstract NAD(P)H Quinone Dehydrogenase 1 (NQO1) plays a pivotal role in the regulation of neuronal function and synaptic plasticity, cellular adaptation to oxidative stress, neuroinflammatory and degenerative processes, and tumorigenesis in the central nervous system (CNS). Impairment of the NQO1 activity in the CNS can result in abnormal neurotransmitter release and clearance, increased oxidative stress, and aggravated cellular injury/death. Furthermore, it can cause disturbances in neural circuit function and synaptic neurotransmission. The abnormalities of NQO1 enzyme activity have been linked to the pathophysiological mechanisms of multiple neurological disorders, including Parkinson's disease, Alzheimer's disease, epilepsy, multiple sclerosis, cerebrovascular disease, traumatic brain injury, and brain malignancy. NQO1 contributes to various dimensions of tumorigenesis and treatment response in various brain tumors. The precise mechanisms through which abnormalities in NQO1 function contribute to these neurological disorders continue to be a subject of ongoing research. Building upon the existing knowledge, the present study reviews current investigations describing the role of NQO1 dysregulations in various neurological disorders. This study emphasizes the potential of NQO1 as a biomarker in diagnostic and prognostic approaches, as well as its suitability as a target for drug development strategies in neurological disorders.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the mechanism of action of NAD(P)H Quinone Dehydrogenase 1 (NQO1) in central nervous system (CNS) diseases and its potential diagnostic, prognostic and therapeutic values. Specifically, the paper focuses on the following aspects: 1. **Function and Regulation of NQO1**: The role of NQO1 in cellular antioxidant stress, neural function regulation, synaptic plasticity, neuroinflammation and degenerative processes, as well as its contribution to tumorigenesis. 2. **Relationship between NQO1 and Neurodegenerative Diseases**: The connection between abnormal NQO1 activity and the pathophysiological mechanisms of various neurodegenerative diseases (such as Parkinson's disease, Alzheimer's disease, epilepsy, multiple sclerosis, cerebrovascular diseases, traumatic brain injury and brain malignancies). 3. **Potential of NQO1 as a Biomarker**: Evaluate the potential of NQO1 as a diagnostic and prognostic marker, especially in neurodegenerative diseases. 4. **Feasibility of NQO1 as a Drug Target**: Discuss the potential of NQO1 as a target for drug development, aiming to provide new strategies for the prevention and treatment of neurodegenerative diseases. 5. **Impact of NQO1 Gene Polymorphisms**: Study the effects of different NQO1 gene polymorphisms on enzyme activity and stability, and the relationship between these polymorphisms and the risk of specific neurodegenerative diseases. By reviewing the current research progress, this paper aims to provide a comprehensive perspective for understanding the mechanism of action of NQO1 in neurodegenerative diseases and explore its potential value in clinical applications.